Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Horger

Showing results (331-340 of 346) with videos related to

Pageof 35
Sort By:
BMC Bioinformatics|February 8, 2022
A data management infrastructure for the integration of imaging and omics data in life sciencesLuis Kuhn Cuellar, Andreas Friedrich, Gisela Gabernet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2022
Antibody-guided Molecular Imaging of Aspergillus Lung Infections in Leukemia PatientsJohannes Schwenck, Andreas Maurer, Nicolas Beziere, et al.
Cancers|December 23, 2020
Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular CarcinomaStephan Spahn, Daniel Roessler, Radu Pompilia, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2019
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcomaJoerg T Hartmann, Hans-G Kopp, Viktor Gruenwald, et al.
Nature Communications|February 12, 2024
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinomaStephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Frontiers in Oncology|November 17, 2022
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinomaLinus D Kloker, Branko Calukovic, Katrin Benzler, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Mycoses|August 12, 2018
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 4, 2023
Photon-counting computed tomography - clinical application in oncological, cardiovascular, and pediatric radiologyFlorian Hagen, Martin Soschynski, Meike Weis, et al.
Pageof 35

Showing results (331-340 of 346) with videos related to

Sort By:
Pageof 35
BMC Bioinformatics|February 8, 2022
A data management infrastructure for the integration of imaging and omics data in life sciencesLuis Kuhn Cuellar, Andreas Friedrich, Gisela Gabernet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2022
Antibody-guided Molecular Imaging of Aspergillus Lung Infections in Leukemia PatientsJohannes Schwenck, Andreas Maurer, Nicolas Beziere, et al.
Cancers|December 23, 2020
Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular CarcinomaStephan Spahn, Daniel Roessler, Radu Pompilia, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2019
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcomaJoerg T Hartmann, Hans-G Kopp, Viktor Gruenwald, et al.
Nature Communications|February 12, 2024
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinomaStephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Frontiers in Oncology|November 17, 2022
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinomaLinus D Kloker, Branko Calukovic, Katrin Benzler, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Mycoses|August 12, 2018
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 4, 2023
Photon-counting computed tomography - clinical application in oncological, cardiovascular, and pediatric radiologyFlorian Hagen, Martin Soschynski, Meike Weis, et al.
Pageof 35